RVMD · Categories · Coverage
RVMD - Analyst coverage initiated
Revolution Medicines Inc. (RVMD) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for RVMD
- Bernstein initiated coverage on Revolution Medicines with a new price targetBernstein initiated coverage of Revolution Medicines with a rating of Mkt Perform and set a new price target of $151.00
- Wolfe Research initiated coverage on Revolution Medicines with a new price targetWolfe Research initiated coverage of Revolution Medicines with a rating of Outperform and set a new price target of $75.00
- RBC Capital Mkts initiated coverage on Revolution Medicines with a new price targetRBC Capital Mkts initiated coverage of Revolution Medicines with a rating of Outperform and set a new price target of $77.00
- Mizuho initiated coverage on Revolution Medicines with a new price targetMizuho initiated coverage of Revolution Medicines with a rating of Outperform and set a new price target of $90.00
- Truist initiated coverage on Revolution Medicines with a new price targetTruist initiated coverage of Revolution Medicines with a rating of Buy and set a new price target of $99.00
- Piper Sandler initiated coverage on Revolution Medicines with a new price targetPiper Sandler initiated coverage of Revolution Medicines with a rating of Overweight and set a new price target of $75.00
- Wells Fargo initiated coverage on Revolution Medicines with a new price targetWells Fargo initiated coverage of Revolution Medicines with a rating of Overweight and set a new price target of $67.00
- Goldman initiated coverage on Revolution Medicines with a new price targetGoldman initiated coverage of Revolution Medicines with a rating of Buy and set a new price target of $65.00
- Barclays initiated coverage on Revolution Medicines with a new price targetBarclays initiated coverage of Revolution Medicines with a rating of Overweight and set a new price target of $52.00
- Jefferies initiated coverage on Revolution Medicines with a new price targetJefferies initiated coverage of Revolution Medicines with a rating of Buy and set a new price target of $63.00
- Piper Sandler initiated coverage on Revolution Medicines with a new price targetPiper Sandler initiated coverage of Revolution Medicines with a rating of Overweight and set a new price target of $43.00
- Wedbush initiated coverage on Revolution Medicines with a new price targetWedbush initiated coverage of Revolution Medicines with a rating of Outperform and set a new price target of $41.00
- Raymond James initiated coverage on Revolution Medicines with a new price targetRaymond James initiated coverage of Revolution Medicines with a rating of Outperform and set a new price target of $30.00
- Needham initiated coverage on Revolution Medicines with a new price targetNeedham initiated coverage of Revolution Medicines with a rating of Buy and set a new price target of $31.00
- Oppenheimer initiated coverage on Revolution Medicines with a new price targetOppenheimer initiated coverage of Revolution Medicines with a rating of Outperform and set a new price target of $30.00
- BofA Securities initiated coverage on Revolution Medicines with a new price targetBofA Securities initiated coverage of Revolution Medicines with a rating of Neutral and set a new price target of $24.00
- Stifel initiated coverage on Revolution Medicines with a new price targetStifel initiated coverage of Revolution Medicines with a rating of Hold and set a new price target of $34.00
- Goldman Sachs initiated coverage on Revolution Medicines with a new price targetGoldman Sachs initiated coverage of Revolution Medicines with a rating of Buy and set a new price target of $49.00